Scott Ernst

Scott Ernst

UNVERIFIED PROFILE

Are you Scott Ernst?   Register this Author

Register author
Scott Ernst

Scott Ernst

Publications by authors named "Scott Ernst"

Are you Scott Ernst?   Register this Author

48Publications

1574Reads

23Profile Views

Early experience with chemotherapy intensification for poor-prognosis metastatic germ cell cancer and unfavorable tumor marker decline.

Can Urol Assoc J 2020 Feb 23;14(2):43-47. Epub 2019 Jul 23.

Division of Medical Oncology, Department of Oncology, Western University and London Health Sciences Centre, London, ON, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.5802DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012285PMC
February 2020

Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations.

J Clin Oncol 2016 Oct;34(30):3655-3663

Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Sabina Signoretti, and Toni K. Choueiri, Dana-Farber Cancer Institute; Wanling Xie, Rana R. McKay, Mark A. Preston, Eunyoung Cho, Sabina Signoretti, and Toni K. Choueiri, Brigham and Women's Hospital; Laurence Albiges, Wanling Xie, Rana R. McKay, Andre P. Fay, Guillermo de Velasco, Eunyoung Cho, David F. McDermott, Sabina Signoretti, and Toni K. Choueiri, Harvard Medical School; Mark A. Preston and Kathryn M. Wilson, Harvard School of Public Health; David F. McDermott, Beth Israel Deaconess Medical Center, Boston, MA; Laurence Albiges, Gustave Roussy, Université Paris-Saclay, Villejuif, France; A. Ari Hakimi, Emily C. Zabor, Anders J. Skanderup, and Helena Furberg, Memorial Sloan Kettering Cancer Center, New York; Ronit Simantov and Xun Lin, Pfizer Oncology, New York, NY; Jae-Lyun Lee, University of Ulsan College of Medicine, Asan; Sun-Young Rha, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea; Brian I. Rini, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH; Sandy Srinivas, Stanford Cancer Institute, Stanford; Sumanta K. Pal, City of Hope Comprehensive Cancer Center, Duarte, CA; Georg A. Bjarnason, Sunnybrook Odette Cancer Center, Toronto; Scott Ernst, London Health Sciences Center, London, Ontario; Lori A. Wood, Queen Elizabeth II Health Sciences Center, Halifax, Nova Scotia; Daniel Y.C. Heng, Tom Baker Cancer Center; University of Calgary, Calgary, Alberta, Canada; Ulka N. Vaishamayan, Karmanos Cancer Center, Detroit, MI; Neeraj Agarwal, University of Utah Huntsman Cancer Institute, Salt Lake City, UT; Takeshi Yuasa, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan; Aristotelis Bamias, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; and Eunyoung Cho, The Warren Alpert Medical School of Brown University; Brown University School of Public Health, Providence, RI.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.66.7311DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5065111PMC
October 2016

Biomarker use is associated with reduced clinical trial failure risk in metastatic melanoma.

Biomark Med 2015 ;9(1):13-23

Biology Department, University of Toronto Mississauga, William Davis Building, Room 2071, Mississauga, ON, L5L 1C6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/bmm.14.80DOI Listing
September 2015

ECF chemotherapy for liver metastases due to castration-resistant prostate cancer.

Can Urol Assoc J 2014 Sep;8(9-10):353-7

Schulich School of Medicine & Dentistry, Western University, London, ON; ; Division of Medical Oncology, Department of Oncology, Western University, London, ON;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5489/cuaj.2029DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216294PMC
September 2014

A phase I study of temsirolimus and metformin in advanced solid tumours.

Invest New Drugs 2012 Apr 27;30(2):647-52. Epub 2010 Oct 27.

London Health Sciences Centre, 790 Commissioners Rd. East, London, ON, Canada N6A 4L6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-010-9570-8DOI Listing
April 2012

A phase II study of the antisense oligonucleotide GTI-2040 plus docetaxel and prednisone as first-line treatment in castration-resistant prostate cancer.

Cancer Chemother Pharmacol 2011 Apr 3;67(4):927-33. Epub 2010 Jul 3.

Princess Margaret Hospital, Phase II Consortium, University of Toronto, 610 University Avenue, Suite 5-222, Toronto, ON M5G 2M9, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-010-1389-7DOI Listing
April 2011

A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer.

Cancer 2010 Jan;116(2):323-30

Department of Surgery, Tom Baker Cancer Center, Suite 212, 1011 Glenmore Trail SW, Calgary, Alberta T2V 4R6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.24779DOI Listing
January 2010

Quality of life 2 years after salvage cryosurgery for the treatment of local recurrence of prostate cancer after radiotherapy.

Urol Oncol 2006 Nov-Dec;24(6):472-86

Department of Oncology and Program in Clinical Psychology, University of Calgary, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2006.03.007DOI Listing
February 2007

Phase II study of perifosine in previously untreated patients with metastatic melanoma.

Invest New Drugs 2005 Dec;23(6):569-75

London Regional Cancer Centre, 790 Commissioners Rd East, London, ON N6A 4L6, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10637-005-1157-4DOI Listing
December 2005

Understanding participation in a trial comparing cryotherapy and radiation treatment.

Can J Urol 2005 Apr;12(2):2607-13

Division of Urology, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
April 2005

Quality of life and sexuality of men with prostate cancer 3 years after cryosurgery.

Urology 2002 Aug;60(2 Suppl 1):12-8

Department of Oncology and Program in Clinical Psychology, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0090-4295(02)01679-5DOI Listing
August 2002

The role of chemotherapy in advanced prostate cancer.

Authors:
D Scott Ernst

Can J Urol 2002 Jun;9 Suppl 1:21-5

Department of Medicine, Tom Baker Cancer Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
June 2002